Previous Article | Next Article 
Journal of Clinical Microbiology, November 1999, p. 3518-3523, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Amplification of Reiterated Sequences of Herpes
Simplex Virus Type 1 (HSV-1) Genome To Discriminate between
Clinical HSV-1 Isolates
J.
Maertzdorf,1
L.
Remeijer,2
A.
Van Der
Lelij,3
J.
Buitenwerf,4
H. G. M.
Niesters,1
A. D. M. E.
Osterhaus,1 and
G.
M. G. M.
Verjans1,2,*
Institute of Virology, Erasmus University
Rotterdam, 3000 DR Rotterdam,1 The
Rotterdam Eye Hospital, 3000 LM Rotterdam,2
Department of Ophthalmology, University Hospital Utrecht, 3508 GA Utrecht,3 and Zuider Ziekenhuis,
3011 EN Rotterdam,4 The Netherlands
Received 27 April 1999/Returned for modification 4 June
1999/Accepted 23 July 1999
 |
ABSTRACT |
Herpes simplex virus type 1 (HSV-1)-related disease ranges from a
localized, self-limiting illness to fatal disease in immunocompromised individuals. The corneal disease herpetic keratitis may develop after
reactivation of a latent virus or reinfection with an exogenous herpesvirus. Molecular analysis of the virus involved may allow distinction between these two options. The HSV-1 genome contains several hypervariable regions that vary in numbers of reiterating regions (reiterations I to VIII [ReI to ReVIII]) between individual strains. Twenty-four HSV-1 clones, derived by subcloning of HSV-1 (strain F) twice in limiting dilutions, were tested in a PCR-based assay to analyze the stabilities of ReI, ReIII, ReIV, and ReVII. ReI
and ReIII proved to vary in size upon subcloning, whereas ReIV and
ReVII were stable. Subsequently, 37 unrelated isolates and 10 sequential isolates from five patients, all with HSV-1-induced keratitis, were genotyped for ReIV and ReVII. Of the 37 unrelated samples, 34 (92%) could be discriminated, while the genotypes of the
viruses in sequential samples were identical for each individual. Conclusively, the data show that the approach presented allows the
rapid and accurate discrimination of HSV-1 strains in studies that
address the transmission and pathogenesis of HSV-1 infections.
 |
INTRODUCTION |
Herpes simplex virus (HSV) type 1 (HSV-1) infections are widespread in the human population and may cause
a variety of disease symptoms, including localized recurrent ocular
lesions like uveitis and keratitis (16). Clinical
manifestations associated with herpetic corneal infections are herpetic
epithelial keratitis and the development of the potentially
cornea-blinding disease herpetic stromal keratitis.
It may be of clinical importance to know whether recurrent corneal
HSV-1 infections are caused by reactivation of a latent virus or
reinfection with an exogenous virus. Genetically different HSV-1
strains can induce different types of ocular lesions (8, 33). Intratypic differences between HSV strains have been
demonstrated by plaque morphology, serology, and DNA restriction
analysis (5, 15, 22). The method generally used to
discriminate HSV-1 strains is restriction fragment length polymorphism
(RFLP) analysis (7, 15, 17-19, 24, 29-31). Since this
technique depends on virus culture to obtain sufficient quantities of
viral DNA, it is unsuitable for rapid diagnosis or when no virus can be
isolated. Vogel et al. (31) reported on an alternative
method for clinical HSV strain differentiation that uses PCR
amplification and subsequent RFLP analysis.
We have chosen to develop a different strategy, based on the
variability of reiterated sequences within the HSV-1 genome. The genome
of HSV-1 consists of a unique long (UL) and a unique short
(US) sequence, each of which is flanked by inverted repeat sequences (14, 32). Several hypervariable regions,
designated reiterations I to VIII (ReI to ReVIII), have been identified
within the HSV-1 genome (Fig. 1). These
regions contain multiple repeating sequences, which vary in numbers
between unrelated HSV-1 strains (3, 9, 10, 13, 24, 25, 28, 34,
35). The stability of these regions varies. ReI, ReIII, ReIV, and
ReVII have been demonstrated to be relatively stable during a short
period of viral replication, and it has been suggested that several of
these hypervariable regions could be used as markers to discriminate HSV-1 strains (27, 28). ReI and ReIII are located within the "a" sequence of the repeat regions that flank the unique short sequence. ReIV is present twice within the HSV-1 genome and is located
within introns of both the genes US1 and US12, whereas ReVII is located
within the protein-coding region of US10 and US11 (3, 11,
13).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Map of HSV-1 genome and location and sequences of the
reiterations tested. (A) The HSV-1 genome contains two covalently
linked components (L and S), each of which consists of unique sequences
(UL and US) flanked by inverted repeat
sequences (IR and TR). The short "a" sequence is located at both
termini of the genome and in the inverse orientation at the L-S
junction (14). The enlargement of the S component shows the
5' 3' orientations of mRNA species as horizontal arrows, with introns
indicated as V-shaped indents. Protein-coding regions are shown as open
boxes. Vertical arrows indicate locations of reiterations, and Roman
numerals indicate locations as defined by Rixon et al. (13).
(B) Reiteration-specific sequences, as indicated by the superscript
numbers, were derived from the indicated HSV-1 strains: 1, MP17; 2, USA-8; 3, F.
|
|
This report describes the development of a PCR method that is used to
discriminate HSV-1 strains and that is based on the variability of
reiterated sequences within the HSV-1 genome. This approach was
successfully used to discriminate 37 unrelated corneal HSV-1 isolates
obtained from patients with herpetic corneal disease. Additionally,
sequential HSV-1 isolates from five herpetic keratitis patients were compared.
 |
MATERIALS AND METHODS |
Clinical samples and viruses.
Corneal swab specimens were
obtained from 37 patients with herpetic keratitis at the Rotterdam Eye
Hospital (Rotterdam, The Netherlands) for diagnostic purposes.
Sequential samples (n = 2) were obtained (mean time
interval, 19 months; range, 9 to 38 months) from 5 patients: from the
same eye for four patients and from different eyes for one patient.
Virus was grown on human embryonic lung fibroblasts and was harvested
when approximately 75% of the monolayer displayed a cytopathic effect.
All culture samples were confirmed to be HSV-1 positive by PCR (data
not shown). To determine the stability of the hypervariable regions, 24 subclones were generated from HSV-1 F (ATCC VR-733) by subcloning twice in limiting dilution as described before (26).
Nucleic acid extraction.
DNA was extracted from 100 µl of
virus culture samples by a guanidinium thiocyanate-Celite binding
method, as described before (1). Briefly, a sample was added
to a tube containing 1 ml of lysis buffer and 40 µl of Celite
suspension (Fischer Scientific, Den Bosch, The Netherlands), mixed, and
incubated for 10 min at room temperature. The Celite-bound DNA was
washed twice with wash buffer, twice with 70% (vol/vol) ethanol, and
once with acetone and was subsequently dried. DNA was extracted by
resuspending the pellet in 150 µl of water at 56°C for 10 min. A
volume of 5 µl of the resulting DNA suspension was used per PCR mixture.
PCR amplification.
Primers were designed to amplify distinct
regions in the HSV-1 genome that contained ReI, ReIII, ReIV, or ReVII.
PCR amplification was performed with several combinations of primers
(Table 1). The PCRs were performed in
50-µl volumes. The reaction mixture contained 1.25 U of cloned
Pfu DNA polymerase (Stratagene Europe, Amsterdam, The
Netherlands), corresponding buffer supplemented with 5% (vol/vol)
dimethyl sulfoxide (DMSO), each of the primers at a concentration of 1 µM, and each deoxynucleoside triphosphate, including equimolar
amounts of dGTP and 7-deaza-2'-dGTP (Boehringer Mannheim, Mannheim,
Germany), at a concentration of 200 µM. A 5-µl sample of the DNA
suspension was added, and the reaction mixtures were overlaid with 50 µl of mineral oil. PCR amplification was carried out as follows: an
initial denaturation step of 95°C for 5 min, followed by 45 cycles of
alternating denaturation (1 min, 95°C), primer annealing (1 min at
the appropriate temperature; Table 1), and primer extension (1 min,
72°C). A final extension step of 7 min at 72°C was included. For
negative control samples, the DNA suspension was replaced by water. All
PCRs were performed in a Perkin-Elmer 480 thermocycler (PE Biosystems,
Nieuwerkerk a/d IJssel, The Netherlands).
Detection of amplified products.
Amplicons were size
fractionated in 2% agarose gels and were visualized by ethidium
bromide staining. The specificities of the amplicons were confirmed by
Southern blotting (20). Briefly, the electrophoresed samples
were transferred onto Hybond N+ membranes (Amersham,
Pharmacia Biotech). Hybridization was performed overnight at 37°C
with [
-32P]ATP-labeled Re-specific oligonucleotides
(Table 1). Posthybridization washes were performed twice with 2× SSC
(1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium
dodecyl sulfate at 37°C for 10 min. The filters were exposed with
intensifying screens at
80°C. In case of small differences in
length between amplicons from individual samples, the DNA fragments
were electrophoresed on denaturing (8 M urea) 6% acrylamide gels
(20). The lengths of the amplicons were estimated by
comparison to a 100-bp DNA ladder (Gibco BRL). To confirm differences
in amplicon length, all samples tested were finally electrophoresed in
order of increasing length.
 |
RESULTS |
Amplification of hypervariable genomic HSV-1 regions containing
ReI, ReIII, ReIV, and ReVII.
On the basis of documented
variability and stability (27, 28), hypervariable regions
containing ReI, ReIII, ReIV, and ReVII were selected as candidate
templates for PCR-mediated discrimination of unrelated HSV-1 strains.
Amplification of these regions was not possible or was insufficient
under standard PCR conditions (data not shown). Alternative
conditions,
selected to decrease the formation of secondary structures
due to the
high G+C contents of these sequences, improved amplification
of the
target sequences and allowed direct visualization of the
amplicons with
ethidium bromide. The specificities of the amplicons
were confirmed by
hybridization with a

-
32P-labeled Re-specific probe
following Southern blotting (Fig.
2).
Consistent results were obtained in all cases in subsequent
experiments.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
Amplification of hypervariable regions within the HSV-1
genome. (A) PCR amplification of regions containing ReI, ReIII, ReIV,
and ReVII was performed with DNA from various HSV-1 (strain F)
subclones. Amplicons were electrophoresed on a 2% agarose gel and were
visualized by ethidium bromide staining. Ten representative samples
from 24 subclones analyzed are shown. Lane F, parental strain HSV-1 F;
lanes 1 to 10, HSV-1 F subclones; lane C, water control; lanes M,
100-bp molecular size marker. Numbers on the left are in base pairs.
(B) Autoradiogram of DNA in gel from panel A after Southern blot
transfer and hybridization with a Re-specific probe.
|
|
To test the stabilities of ReI, ReIII, ReIV, and ReVII, PCR
amplification of these regions was performed with 24 separate
subclones
of HSV-1 F, and the sequences of these regions were
compared with those
of the amplicons of the parental strains (Fig.
2). For the regions
containing ReIV and ReVII, amplicons from
all 24 subclones were
identical in size to those of their parental
strains, indicating the
stability of ReIV and ReVII during the
two limiting dilution rounds.
For the regions containing ReI and
ReIII, not all separate subclones
showed the same amplicon length
as their parental strains, differences
being greatest for ReIII
(Fig.
2). Consequently, ReIV and ReVII were
further used to discriminate
37 unrelated HSV-1 isolates obtained from
keratitis patients.
The results of the analyses performed with all 37 clinical corneal
HSV-1 isolates are summarized in Table
2. As an example, differences
in amplicon
lengths between unrelated clinical isolates from 10
patients are shown
in Fig.
3A. The variability in the
US10-US11
region (ReVII) was low, showing only three different alleles.
Regions US1 and US12 (ReIV) showed a wider variety of alleles,
with 14 and 15 different alleles detected among the 37 samples
analyzed,
respectively (Table
2). Combination of the results
for the three
amplified regions showed that 34 of the 37 isolates
(92%) displayed
unique combinations of amplicons. For some clinical
samples, no PCR
product could be detected by ethidium bromide
staining or multiple
fragments appeared. This was probably due
to the poor quality of the
template DNA. Hybridization with the
labeled probe, however, readily
enabled the detection of the Re-specific
amplicon in these samples
(data not shown).

View larger version (93K):
[in this window]
[in a new window]
|
FIG. 3.
Variability of Re-containing regions US1, US12, and
US10-US11 between unrelated and sequential corneal HSV-1 isolates. PCR
amplification was performed with DNA from corneal HSV-1 isolates.
Amplicons were analyzed as described in the legend to Fig. 2. (A)
Results for 10 representative samples among the 37 samples analyzed.
(B) Amplicons from sequential samples from five individuals. Lane C,
water control; lanes M, 100-bp molecular size marker. Numbers on the
left are in base pairs.
|
|
Analysis of sequential corneal HSV-1 isolates.
Sequential
corneal HSV-1 isolates obtained from five patients with recurrent
herpetic corneal infections were analyzed (Fig. 3; Table 2). The ReIV-
and ReVII-specific amplicons showed interindividual variations in
length. However, the amplicons from the sequential samples from each
individual were identical.
 |
DISCUSSION |
In the present paper, we present a PCR-based approach that allows
the rapid and accurate discrimination of unrelated HSV-1 strains. The
method generally used to discriminate HSV-1 strains is RFLP analysis
(7, 15, 17-19, 24, 29-31). This method requires virus
culture, is time-consuming, and is highly labor-intensive. Furthermore,
culture requires viable virus, which is not always obtainable from
certain types of clinical samples (e.g., cerebrospinal and intraocular
fluids). More recently, a system that uses PCR amplification and
subsequent RFLP analysis has been developed to facilitate
discrimination of HSV-1 strains, eliminating the necessity of virus
culture. This method, however, is not significantly less time-consuming
or labor-intensive than conventional strain differentiation
(31).
Conventional RFLP analysis with restriction endonucleases that
recognize 6 bp (6-bp REs) is insufficient for differentiation of HSV-1
strains of a predominant genotype. The use of 4-bp REs and RFLP
analyses of reiterated sequences greatly improved the differentiation
rate (28). As in our study, the RFLP analysis of reiterated
sequences was based on various numbers of repeats. Use of both
techniques generated similar results, verifying the applicability of
either method in molecular epidemiological studies (27, 28).
Similar hypervariable regions have been used successfully to
discriminate strains of other herpesviruses like Epstein-Barr virus and
human cytomegalovirus (23, 36).
To be applicable in a PCR-based assay for discrimination of different
HSV-1 strains, these regions should show a considerable degree of
variability and should remain stable during a relatively short time of
replication. We tested the suitability of several HSV-1 hypervariable
regions for discrimination of unrelated HSV-1 strains.
Due to their G+C-rich sequences, standard PCR protocols failed to
reproducibly amplify the regions tested. The high G+C content increases
the formation of secondary structures, preventing consistent amplification of the repeats. We tested a number of PCR conditions in
order to obtain consistent DNA amplification. Addition of DMSO as a
cosolvent to the reaction mixture has previously been shown to
facilitate DNA amplification of G+C-rich sequences (12). Introduction of the exonuclease activity of the Pfu DNA
polymerase enzyme in the PCR mixture prevents "skipping" of the
repeats, which could result in the formation of products smaller than
the actual size of the template repeat (2). Another
modification was the introduction of 7-deaza-2'-dGTP. This analogue of
dGTP is equally well incorporated into DNA but exerts a lesser binding strength to dCTP than normal dGTP (6, 21). The use of
Pfu polymerase, 50% 7-deaza-2'-dGTP as a replacement for
100% dGTP, and 5% DMSO resulted in the most consistent amplification
of the large alleles. The specificities of the amplicons were confirmed by hybridization with Re-specific probes after Southern blotting.
Analysis of subclones of HSV-1 F showed that the stability of the ReI
and ReIII sequences was too low to be useful for discrimination of
HSV-1 strains. In contrast, ReIV and ReVII were shown to be stable
during this procedure. Thus, regions US1 (ReIV), US12 (ReIV), and
US10-US11 (ReVII) were chosen for use in the discrimination of
unrelated corneal HSV-1 isolates.
In agreement with previous studies, the variability in the US10-US11
region was found to be relatively low (27-29). We detected only three different alleles among 37 unrelated clinical HSV-1 isolates, which is not surprising since ReVII is located within a
protein-coding region, making it a target for selective pressure. More
drastic changes in the length of US10-US11 could influence the
translation or function of the proteins encoded by genes US10 and US11.
In contrast, the ReIV-containing sequences are located in the introns
of genes US1 and US12. We found 14 and 15 different alleles for regions
US1 and US12, respectively, in the 37 corneal HSV-1 isolates analyzed.
Comparison of the alleles from the three regions for all 37 corneal
HSV-1 isolates revealed 34 unique combinations. The isolates with
identical combinations were obtained at different time points,
indicating that this was most likely not due to contamination during
virus isolation or culture procedures.
Sequential corneal isolates from five individuals with recurrent
herpetic corneal infections were analyzed. For each individual, sequential samples showed identical DNA patterns, while the patterns for samples from different patients were different. These results indicate that the recurrent infections were most likely caused by the
same virus. A comparative sequence database search revealed several
point mutations between different HSV-1 strains, in addition to various
numbers of repeats. More detailed analysis, like sequencing of the
amplicons, might provide more conclusive evidence for this assumption.
This also demonstrates that these hypervariable regions remain stable
during reactivation and replication of latent HSV-1 in the corneas of
these individuals.
Additionally, we have also analyzed clinical samples in which no viable
virus can usually be detected (4). Re sequence-specific PCR
analyses were performed with DNA isolated from affected corneal buttons
and rims obtained from patients with herpetic stromal keratitis during
therapeutic keratoplasty. The PCR approach proved to be sensitive
enough for amplification of the low levels of viral DNA present in
these samples (unpublished data). The major advantage of the approach
presented is that it provides the opportunity to discriminate HSV-1
strains without virus culture or RFLP analysis, making it convenient
for rapid diagnostic testing. Although not suitable for classification
of HSV-1 strains, it provides a powerful tool that can be used to
address questions regarding reactivation and the modes of transmission
of HSV-1. For example, it could be used to assess the risk of HSV-1
transmission through cornea transplantation and other manifestations of
recurrent HSV-1 infections.
 |
ACKNOWLEDGMENTS |
This work was supported by grants "Fischer Stichting" (to
J.M.) and "Stichting Wetenschappelijk Onderzoek Oogziekenhuis"
(to G.M.G.M.V. and L.R.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Virology, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR
Rotterdam, The Netherlands. Phone: (31) 10-4088066. Fax: (31)
10-4089485. E-mail: verjans{at}viro.fgg.eur.nl.
 |
REFERENCES |
| 1.
|
Boom, R.,
C. J. Sol,
M. M. Salimans,
C. L. Jansen,
P. M. Wertheim-van Dillen, and J. van der Noordaa.
1990.
Rapid and simple method for purification of nucleic acids.
J. Clin. Microbiol.
28:495-503[Abstract/Free Full Text].
|
| 2.
|
Chong, S. S.,
E. E. Eichler,
D. L. Nelson, and M. R. Hughes.
1994.
Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase.
Am. J. Med. Genet.
51:522-526[Medline].
|
| 3.
|
Davison, A. J., and N. M. Wilkie.
1981.
Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2.
J. Gen. Virol.
55:315-331[Abstract/Free Full Text].
|
| 4.
|
Easty, D. L.,
C. Shimeld,
C. M. Claoue, and M. Menage.
1987.
Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies.
Curr. Eye Res.
6:69-74[Medline].
|
| 5.
|
Ejercito, P. M.,
E. D. Kieff, and B. Roizman.
1968.
Characterization of herpes simplex virus strains differing in their effects on the social behavior of infected cells.
J. Gen. Virol.
2:357-364[Abstract/Free Full Text].
|
| 6.
|
Fernandez-Rachubinski, F.,
B. Eng,
W. W. Murray,
M. A. Blajchman, and R. A. Rachubinski.
1990.
Incorporation of 7-deaza dGTP during the amplification step in the polymerase chain reaction procedure improves subsequent DNA sequencing.
DNA Seq.
1:137-140[Medline].
|
| 7.
|
Haugen, T. H.,
B. Alden,
S. Matthey, and D. Nicholson.
1993.
Restriction enzyme fragment length polymorphisms of amplified herpes simplex virus type-1 DNA provide epidemiologic information.
Virology
17:129-133.
|
| 8.
|
Kintner, R. L.,
R. W. Allan, and C. R. Brandt.
1995.
Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.
Arch. Virol.
140:231-244[Medline].
|
| 9.
|
McGeoch, D. J.,
A. Dolan,
S. Donald, and D. H. K. Brauer.
1986.
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.
Nucleic Acids Res.
14:1727-1745[Abstract/Free Full Text].
|
| 10.
|
Mocarski, E. S.,
L. E. Post, and B. Roizman.
1980.
Molecular engineering of the herpes simplex virus genome: domain and structural features.
Proc. Natl. Acad. Sci. USA
78:7047-7051.
|
| 11.
|
Murchie, M.-J., and D. J. McGeoch.
1982.
DNA sequence analysis of an immediate-early gene region of the herpes simplex virus type 1 genome (map coordinates 0.950 to 0.0978).
J. Gen. Virol.
62:1-15[Abstract/Free Full Text].
|
| 12.
|
Paragas, J., and J. A. Blaho.
1998.
Cosolvents facilitate DNA synthesis in the herpes simplex virus 1 unique short (Us) inverted repeat.
J. Virol. Methods
73:53-58[Medline].
|
| 13.
|
Rixon, F. J.,
M. E. Campbell, and J. B. Clements.
1984.
A tandemly reiterated DNA sequence in the long repeat region of herpes simplex virus type 1 found in close proximity to immediate-early mRNA 1.
J. Virol.
52:715-718[Abstract/Free Full Text].
|
| 14.
|
Roizman, B.
1979.
The structure and isomerization of herpes simplex virus genomes.
Cell
16:481-494[Medline].
|
| 15.
|
Roizman, B., and M. Tognon.
1983.
Restriction endonuclease patterns of herpes simplex virus DNA: application to diagnosis and molecular epidemiology.
Curr. Top. Microbiol. Immunol.
104:273-286[Medline].
|
| 16.
|
Roizman, B., and A. E. Sears.
1996.
Herpes simplex viruses and their replication, p. 2231-2295.
In
B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed., vol. 1. Raven Press, New York, N.Y
|
| 17.
|
Sakaoka, H.,
T. Aomori,
H. Saito,
S. Sato,
R. Kawana,
D. T. Hazlett, and K. Fujinaga.
1986.
A comparative analysis by restriction endonucleases of herpes simplex virus type 1 isolated in Japan and Kenya.
J. Infect. Dis.
153:612-616[Medline].
|
| 18.
|
Sakaoka, H.,
H. Saito,
K. Sekine,
T. Aomori,
L. Grillner,
G. Wadell, and K. Fujinaga.
1987.
Genomic comparison of herpes simplex virus type 1 isolates from Japan, Sweden, and Kenya.
J. Gen. Virol.
68:749-764[Abstract/Free Full Text].
|
| 19.
|
Sakaoka, H.,
K. Kurita,
Y. Iida,
S. Takada,
K. Umene,
Y. T. Kim,
C. S. Ren, and A. J. Nahmias.
1994.
Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus.
J. Gen. Virol.
75:513-527[Abstract/Free Full Text].
|
| 20.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
|
| 21.
|
Seela, F., and A. Rolling.
1992.
7-Deazapurine containing DNA: efficiency of c7GdTP, c7AdTP and c7IdTP incorporation during PCR amplification and protection from endo deoxyribonuclease hydrolysis.
Nucleic Acids Res.
20:55-61[Abstract/Free Full Text].
|
| 22.
|
Seth, P.,
W. E. Rawls,
R. Duff,
F. Rapp,
E. Adam, and J. L. Melnick.
1974.
Antigenic differences between isolates of herpesvirus type 2.
Intervirology
3:1-14[Medline].
|
| 23.
|
Triantos, D.,
A. W. Boulter,
J. C. Leao,
L. D. Alberti,
S. R. Porter,
C. M. Scully,
W. Birnbaum,
N. W. Johnson, and C. G. Teo.
1998.
Diversity of naturally occurring Epstein-Barr virus revealed by nucleotide sequence polymorphism in hypervariable domains in the BamHI K and N subgenomic regions.
J. Gen. Virol.
79:2809-2817[Abstract].
|
| 24.
|
Umene, K.,
T. Eto,
R. Mori,
Y. Takagi, and L. W. Enquist.
1984.
Herpes simplex virus type 1 restriction fragment polymorphism determined using Southern hybridization.
Arch. Virol.
80:275-290[Medline].
|
| 25.
|
Umene, K.,
R. J. Watson, and L. W. Enquist.
1984.
Tandem repeat DNA in an intergenic region of herpes simplex virus type 1 (Patton).
Gene
30:33-39[Medline].
|
| 26.
|
Umene, K., and L. W. Enquist.
1985.
Isolation of novel herpes simplex virus type 1 derivatives with tandem duplications of DNA sequences encoding immediate-early mRNA-5 and an origin of replication.
J. Virol.
53:607-615[Abstract/Free Full Text].
|
| 27.
|
Umene, K., and M. Yoshida.
1989.
Reiterated sequences of herpes simplex virus type 1 (HSV-1) genome can serve as physical markers for the differentiation of HSV-1 strains.
Arch. Virol.
106:281-299[Medline].
|
| 28.
|
Umene, K., and H. Sakaoka.
1991.
Homogeneity and diversity of genome polymorphism in a set of herpes simplex type 1 strains classified as the same genotypic group.
Arch. Virol.
119:53-65[Medline].
|
| 29.
|
Umene, K., and M. Yoshida.
1993.
Genomic characterization of two predominant genotypes of herpes simplex virus type 1.
Arch. Virol.
131:29-46[Medline].
|
| 30.
|
Umene, K., and M. Yoshida.
1994.
Preparation of herpes simplex virus type 1 genomic markers to differentiate strains of predominant genotypes.
Arch. Virol.
138:55-69[Medline].
|
| 31.
|
Vogel, J.-U.,
B. Weber, and H. W. Doerr.
1994.
Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent fragment length polymorphism analysis.
Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis.
281:502-512.
|
| 32.
|
Wadsworth, S.,
R. J. Jacob, and B. Roizman.
1975.
Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions.
J. Virol.
15:1487-1497[Abstract/Free Full Text].
|
| 33.
|
Wander, A. H.,
Y. M. Centifanto, and H. E. Kaufman.
1980.
Strain specificity of clinical isolates of herpes simplex virus.
Arch. Ophthalmol.
98:1458-1461[Abstract/Free Full Text].
|
| 34.
|
Watson, R. J.,
K. Umene, and L. W. Enquist.
1981.
Reiterated sequences within the intron of an immediate-early gene of herpes simplex virus type 1.
Nucleic Acids Res.
9:4189-4199[Abstract/Free Full Text].
|
| 35.
|
Watson, R. J., and G. F. Van de Woude.
1982.
DNA sequence of an immediate-early gene (IE mRNA-5) of herpes simplex virus type 1.
Nucleic Acids Res.
10:979-991[Abstract/Free Full Text].
|
| 36.
|
Zaia, J. A.,
G. Gallez-Hawkings,
M. A. Churchill,
A. Morton-Blackshere,
H. Pande,
S. P. Adler,
G. M. Schmidt, and S. J. Forman.
1990.
Comparative analysis of human cytomegalovirus a-sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assays.
J. Clin. Microbiol.
28:2602-2607[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, November 1999, p. 3518-3523, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Deback, C., Boutolleau, D., Depienne, C., Luyt, C. E., Bonnafous, P., Gautheret-Dejean, A., Garrigue, I., Agut, H.
(2009). Utilization of Microsatellite Polymorphism for Differentiating Herpes Simplex Virus Type 1 Strains. J. Clin. Microbiol.
47: 533-540
[Abstract]
[Full Text]
-
Martin, E. T., Koelle, D. M., Byrd, B., Huang, M.-L., Vieira, J., Corey, L., Wald, A.
(2006). Sequence-based methods for identifying epidemiologically linked herpes simplex virus type 2 strains.. J. Clin. Microbiol.
44: 2541-2546
[Abstract]
[Full Text]
-
Umene, K., Kawana, T.
(2003). Divergence of reiterated sequences in a series of genital isolates of herpes simplex virus type 1 from individual patients. J. Gen. Virol.
84: 917-923
[Abstract]
[Full Text]
-
Remeijer, L., Maertzdorf, J., Buitenwerf, J., Osterhaus, A. D. M. E., Verjans, G. M. G. M.
(2002). Corneal Herpes Simplex Virus Type 1 Superinfection in Patients with Recrudescent Herpetic Keratitis. IOVS
43: 358-363
[Abstract]
[Full Text]